A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO EVALUATE MAVACAMTEN IN ADULTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY WHO ARE ELIGIBLE FOR SEPTAL REDUCTION THERAPY
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
